CHAPTER 23-23.1LAETRILE23-23.1-01. Use of laetrile authorized. No hospital or health facility may interfere withthe physician-patient relationship by restricting or forbidding the use of amygdalin when prescribed or administered by a licensed physician and requested by a patient unless the substance as prescribed or administered by the physician is found to be harmful by the state board of medical examiners in a hearing conducted pursuant to chapter 28-32.23-23.1-02. Disciplinary action for administering or prescribing laetrile subject tofinding of harmfulness. No physician may be subject to disciplinary action by the state board of medical examiners for prescribing or administering amygdalin to a patient under the physician's care who has requested the substance unless the board, in a hearing conducted pursuant to chapter 28-32, has made a formal finding that the substance is harmful.23-23.1-03. Hearing of board on effects of laetrile - Rules. Any person may petition,or the board on its own motion may convene, a public hearing to determine the effects of the use of amygdalin and to promulgate rules and regulations pursuant to chapter 28-32 as to its use and administration.Page No. 1Document Outlinechapter 23-23.1 laetrile
CHAPTER 23-23.1LAETRILE23-23.1-01. Use of laetrile authorized. No hospital or health facility may interfere withthe physician-patient relationship by restricting or forbidding the use of amygdalin when prescribed or administered by a licensed physician and requested by a patient unless the substance as prescribed or administered by the physician is found to be harmful by the state board of medical examiners in a hearing conducted pursuant to chapter 28-32.23-23.1-02. Disciplinary action for administering or prescribing laetrile subject tofinding of harmfulness. No physician may be subject to disciplinary action by the state board of medical examiners for prescribing or administering amygdalin to a patient under the physician's care who has requested the substance unless the board, in a hearing conducted pursuant to chapter 28-32, has made a formal finding that the substance is harmful.23-23.1-03. Hearing of board on effects of laetrile - Rules. Any person may petition,or the board on its own motion may convene, a public hearing to determine the effects of the use of amygdalin and to promulgate rules and regulations pursuant to chapter 28-32 as to its use and administration.Page No. 1Document Outlinechapter 23-23.1 laetrile
CHAPTER 23-23.1LAETRILE23-23.1-01. Use of laetrile authorized. No hospital or health facility may interfere withthe physician-patient relationship by restricting or forbidding the use of amygdalin when prescribed or administered by a licensed physician and requested by a patient unless the substance as prescribed or administered by the physician is found to be harmful by the state board of medical examiners in a hearing conducted pursuant to chapter 28-32.23-23.1-02. Disciplinary action for administering or prescribing laetrile subject tofinding of harmfulness. No physician may be subject to disciplinary action by the state board of medical examiners for prescribing or administering amygdalin to a patient under the physician's care who has requested the substance unless the board, in a hearing conducted pursuant to chapter 28-32, has made a formal finding that the substance is harmful.23-23.1-03. Hearing of board on effects of laetrile - Rules. Any person may petition,or the board on its own motion may convene, a public hearing to determine the effects of the use of amygdalin and to promulgate rules and regulations pursuant to chapter 28-32 as to its use and administration.Page No. 1Document Outlinechapter 23-23.1 laetrile